A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some patients with NSCLC but do not impact survival.

cancer to stage 4 cancer, in which multiple organs may be affected. Several different staging systems for non-small cell lung cancer (NSCLC) are used worldwide, but the most widely used approach ...

Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) ...

Approval based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo ...

Extensive: Cancer has spread to other places in the body. Learn more about small cell lung cancer staging from the National Cancer Institute. New findings highlight the positive impact of personalized ...

Among patients with non-small cell lung cancer treated with resection ... from either the seventh or eighth edition of the AJCC Cancer Staging Manual (n = 60,695; 85 studies), researchers observed ...

A recent study from the Women’s Guild Lung Institute at Cedars-Sinai suggests that zinc could help reverse lung damage in patients with idiopathic pulmonary fibrosis (IPF). The findings, published in ...

Similarly, the Alliance is now supporting the Staging Project, which started in 1997 as a means to reduce the wide variations and disparities in lung cancer staging, which is critical when ...